Christopher Evans
Concepts (484)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucus | 16 | 2025 | 77 | 5.150 |
Why?
| | Mucins | 23 | 2025 | 70 | 4.780 |
Why?
| | Mucin-5B | 24 | 2025 | 215 | 2.860 |
Why?
| | Mucin 5AC | 19 | 2025 | 70 | 2.610 |
Why?
| | Lung | 38 | 2025 | 3928 | 2.430 |
Why?
| | Mucociliary Clearance | 7 | 2021 | 42 | 1.860 |
Why?
| | Respiratory Mucosa | 19 | 2025 | 310 | 1.830 |
Why?
| | Bronchial Hyperreactivity | 6 | 2025 | 109 | 1.820 |
Why?
| | Asthma | 11 | 2025 | 2225 | 1.790 |
Why?
| | Lung Diseases, Obstructive | 3 | 2023 | 46 | 1.620 |
Why?
| | Idiopathic Pulmonary Fibrosis | 13 | 2025 | 634 | 1.340 |
Why?
| | Expectorants | 4 | 2023 | 24 | 1.200 |
Why?
| | Fucosyltransferases | 1 | 2025 | 32 | 0.930 |
Why?
| | Animals | 67 | 2025 | 35334 | 0.920 |
Why?
| | Electric Conductivity | 1 | 2024 | 94 | 0.900 |
Why?
| | Vagus Nerve | 4 | 2023 | 86 | 0.900 |
Why?
| | Alveolar Epithelial Cells | 3 | 2024 | 107 | 0.890 |
Why?
| | Electrolytes | 1 | 2024 | 58 | 0.890 |
Why?
| | Bronchioles | 4 | 2024 | 23 | 0.840 |
Why?
| | Quantum Dots | 3 | 2012 | 34 | 0.830 |
Why?
| | Mice | 46 | 2025 | 16973 | 0.820 |
Why?
| | Lung Injury | 3 | 2024 | 211 | 0.810 |
Why?
| | Reflex | 1 | 2023 | 65 | 0.790 |
Why?
| | Respiratory System | 6 | 2020 | 155 | 0.780 |
Why?
| | Disulfides | 2 | 2022 | 97 | 0.730 |
Why?
| | Disease Models, Animal | 20 | 2025 | 4073 | 0.720 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 65 | 0.700 |
Why?
| | Homeostasis | 6 | 2020 | 605 | 0.690 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2024 | 998 | 0.680 |
Why?
| | Mice, Inbred C57BL | 29 | 2025 | 5468 | 0.670 |
Why?
| | Peptides | 1 | 2024 | 925 | 0.610 |
Why?
| | Pulmonary Alveoli | 5 | 2025 | 403 | 0.570 |
Why?
| | Mice, Transgenic | 14 | 2020 | 2135 | 0.560 |
Why?
| | Hypersensitivity | 1 | 2021 | 249 | 0.560 |
Why?
| | Eosinophilia | 1 | 2020 | 204 | 0.560 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 90 | 0.510 |
Why?
| | Epithelial Cells | 10 | 2019 | 1061 | 0.510 |
Why?
| | Receptors, Muscarinic | 4 | 2001 | 20 | 0.500 |
Why?
| | Selenium Compounds | 2 | 2012 | 21 | 0.500 |
Why?
| | Chalcogens | 2 | 2012 | 3 | 0.490 |
Why?
| | Cadmium Compounds | 2 | 2012 | 31 | 0.490 |
Why?
| | Macrophages | 4 | 2024 | 1486 | 0.460 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 493 | 0.450 |
Why?
| | Lung Diseases | 2 | 2018 | 741 | 0.420 |
Why?
| | Uteroglobin | 6 | 2024 | 23 | 0.420 |
Why?
| | Inflammation | 11 | 2022 | 2741 | 0.410 |
Why?
| | Lung Neoplasms | 5 | 2018 | 2342 | 0.400 |
Why?
| | Eosinophils | 4 | 2021 | 324 | 0.390 |
Why?
| | Cadmium | 1 | 2012 | 67 | 0.390 |
Why?
| | Mice, Inbred BALB C | 8 | 2021 | 1248 | 0.380 |
Why?
| | Surface-Active Agents | 1 | 2012 | 86 | 0.380 |
Why?
| | Cystic Fibrosis | 7 | 2021 | 1067 | 0.380 |
Why?
| | Intracellular Space | 1 | 2012 | 69 | 0.370 |
Why?
| | Immunity, Innate | 5 | 2019 | 804 | 0.370 |
Why?
| | Mice, Knockout | 13 | 2025 | 2887 | 0.360 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1211 | 0.360 |
Why?
| | Humans | 50 | 2025 | 129527 | 0.350 |
Why?
| | Glycosylation | 2 | 2025 | 153 | 0.350 |
Why?
| | Ribonucleases | 3 | 2000 | 54 | 0.350 |
Why?
| | Organoselenium Compounds | 1 | 2010 | 11 | 0.350 |
Why?
| | Transcription Factors | 1 | 2018 | 1642 | 0.340 |
Why?
| | Bronchi | 3 | 2016 | 249 | 0.330 |
Why?
| | Exocytosis | 3 | 2019 | 88 | 0.330 |
Why?
| | Gene Expression Regulation | 6 | 2025 | 2544 | 0.320 |
Why?
| | Cilia | 4 | 2022 | 180 | 0.320 |
Why?
| | Polymers | 2 | 2024 | 479 | 0.320 |
Why?
| | Mucous Membrane | 4 | 2021 | 125 | 0.300 |
Why?
| | Airway Obstruction | 2 | 2016 | 154 | 0.300 |
Why?
| | Intestinal Mucosa | 3 | 2022 | 593 | 0.280 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 819 | 0.270 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2022 | 97 | 0.260 |
Why?
| | Ovalbumin | 7 | 2015 | 177 | 0.250 |
Why?
| | Munc18 Proteins | 2 | 2019 | 23 | 0.250 |
Why?
| | Gene Expression | 4 | 2018 | 1461 | 0.250 |
Why?
| | Colloids | 3 | 2019 | 58 | 0.230 |
Why?
| | Phagocytosis | 3 | 2016 | 362 | 0.230 |
Why?
| | Anti-Inflammatory Agents | 2 | 2015 | 481 | 0.230 |
Why?
| | Hydrogen Bonding | 1 | 2024 | 149 | 0.220 |
Why?
| | Th2 Cells | 4 | 2017 | 171 | 0.210 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 3 | 2024 | 44 | 0.210 |
Why?
| | Bronchoalveolar Lavage Fluid | 6 | 2022 | 646 | 0.210 |
Why?
| | Female | 32 | 2024 | 68650 | 0.210 |
Why?
| | Energy Metabolism | 2 | 2024 | 864 | 0.200 |
Why?
| | Regeneration | 1 | 2024 | 182 | 0.200 |
Why?
| | Salts | 1 | 2023 | 37 | 0.200 |
Why?
| | Bleomycin | 5 | 2024 | 243 | 0.200 |
Why?
| | Glycosyltransferases | 1 | 2022 | 13 | 0.200 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2022 | 11 | 0.200 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.200 |
Why?
| | Receptor, Muscarinic M2 | 5 | 2005 | 9 | 0.200 |
Why?
| | MicroRNAs | 3 | 2019 | 677 | 0.200 |
Why?
| | Bronchiectasis | 1 | 2024 | 110 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2271 | 0.200 |
Why?
| | Fibroblasts | 2 | 2025 | 943 | 0.200 |
Why?
| | Glycoproteins | 2 | 2022 | 338 | 0.190 |
Why?
| | Glycolysis | 1 | 2024 | 313 | 0.190 |
Why?
| | Golgi Apparatus | 1 | 2022 | 100 | 0.190 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 477 | 0.190 |
Why?
| | Colon | 2 | 2022 | 257 | 0.190 |
Why?
| | Pulmonary Emphysema | 1 | 2024 | 275 | 0.190 |
Why?
| | Immunohistochemistry | 4 | 2015 | 1684 | 0.190 |
Why?
| | Haemophilus influenzae | 4 | 2010 | 64 | 0.190 |
Why?
| | Pulmonary Eosinophilia | 1 | 2001 | 27 | 0.180 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 187 | 0.180 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 391 | 0.180 |
Why?
| | Metaplasia | 5 | 2008 | 57 | 0.180 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 385 | 0.180 |
Why?
| | Male | 24 | 2024 | 63586 | 0.170 |
Why?
| | Substance P | 1 | 2000 | 43 | 0.170 |
Why?
| | Pseudomonas Infections | 2 | 2020 | 222 | 0.170 |
Why?
| | Leukocyte Count | 1 | 2021 | 324 | 0.170 |
Why?
| | Macrophages, Alveolar | 2 | 2024 | 389 | 0.170 |
Why?
| | Blood Proteins | 3 | 2000 | 244 | 0.170 |
Why?
| | Mustard Gas | 1 | 2021 | 103 | 0.170 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 114 | 0.170 |
Why?
| | Allergens | 2 | 2015 | 385 | 0.160 |
Why?
| | Antigens | 4 | 2007 | 356 | 0.160 |
Why?
| | Syndecan-1 | 1 | 2019 | 28 | 0.160 |
Why?
| | Gene Targeting | 2 | 2018 | 81 | 0.160 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 84 | 0.160 |
Why?
| | Butadienes | 2 | 2009 | 36 | 0.160 |
Why?
| | Polystyrenes | 2 | 2009 | 36 | 0.160 |
Why?
| | Receptors, Interleukin-1 | 1 | 2020 | 216 | 0.150 |
Why?
| | Colitis, Ulcerative | 1 | 2020 | 120 | 0.150 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 67 | 0.150 |
Why?
| | Hypoxia | 2 | 2017 | 1081 | 0.150 |
Why?
| | Interleukin-13 | 3 | 2019 | 147 | 0.150 |
Why?
| | Dexamethasone | 1 | 2001 | 347 | 0.150 |
Why?
| | Cysts | 1 | 2019 | 108 | 0.150 |
Why?
| | Bone Marrow Cells | 2 | 2017 | 302 | 0.150 |
Why?
| | Guinea Pigs | 5 | 2005 | 157 | 0.150 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 462 | 0.150 |
Why?
| | Paraquat | 1 | 2018 | 14 | 0.140 |
Why?
| | Herbicides | 1 | 2018 | 23 | 0.140 |
Why?
| | Macrophage Activation | 1 | 2019 | 189 | 0.140 |
Why?
| | Signal Transduction | 8 | 2022 | 4916 | 0.140 |
Why?
| | Colitis | 1 | 2020 | 245 | 0.140 |
Why?
| | Methacholine Chloride | 2 | 2015 | 52 | 0.140 |
Why?
| | Thrombospondin 1 | 1 | 2017 | 26 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 129 | 0.140 |
Why?
| | Schistosoma | 1 | 2017 | 28 | 0.140 |
Why?
| | Transgenes | 1 | 2018 | 177 | 0.130 |
Why?
| | Mucin-2 | 1 | 2016 | 2 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1684 | 0.130 |
Why?
| | Bacteria | 3 | 2020 | 812 | 0.130 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 126 | 0.130 |
Why?
| | Mast Cells | 2 | 2021 | 142 | 0.130 |
Why?
| | Leukocytes | 2 | 2016 | 304 | 0.130 |
Why?
| | Carcinogenesis | 1 | 2018 | 211 | 0.130 |
Why?
| | Glucocorticoids | 1 | 2001 | 583 | 0.130 |
Why?
| | Bronchitis, Chronic | 1 | 2016 | 19 | 0.130 |
Why?
| | Cytokines | 6 | 2021 | 2018 | 0.130 |
Why?
| | Survival Analysis | 3 | 2018 | 1270 | 0.130 |
Why?
| | Kartagener Syndrome | 1 | 2016 | 30 | 0.130 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 121 | 0.130 |
Why?
| | Bronchoconstriction | 2 | 2011 | 31 | 0.130 |
Why?
| | Neurons | 2 | 2005 | 1509 | 0.130 |
Why?
| | Neutrophils | 3 | 2017 | 1209 | 0.120 |
Why?
| | Thiocyanates | 1 | 2015 | 31 | 0.120 |
Why?
| | Qc-SNARE Proteins | 1 | 2015 | 7 | 0.120 |
Why?
| | Qb-SNARE Proteins | 1 | 2015 | 6 | 0.120 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 49 | 0.120 |
Why?
| | Aspergillus oryzae | 1 | 2015 | 4 | 0.120 |
Why?
| | Models, Biological | 2 | 2013 | 1717 | 0.120 |
Why?
| | Deoxycytidine Kinase | 1 | 2014 | 3 | 0.120 |
Why?
| | Mutation | 5 | 2018 | 3702 | 0.120 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 9 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2774 | 0.110 |
Why?
| | Acute Lung Injury | 1 | 2017 | 280 | 0.110 |
Why?
| | Polysaccharides | 1 | 2014 | 86 | 0.110 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1416 | 0.110 |
Why?
| | Species Specificity | 1 | 2015 | 568 | 0.110 |
Why?
| | Microbiota | 1 | 2021 | 734 | 0.100 |
Why?
| | Smoking | 2 | 2018 | 1501 | 0.100 |
Why?
| | Ear, Middle | 1 | 2013 | 91 | 0.100 |
Why?
| | Valerates | 1 | 2013 | 3 | 0.100 |
Why?
| | Bed Rest | 1 | 2013 | 14 | 0.100 |
Why?
| | Adenosine Triphosphate | 3 | 2022 | 475 | 0.100 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3181 | 0.100 |
Why?
| | Semiconductors | 1 | 2012 | 37 | 0.100 |
Why?
| | Genes, Essential | 1 | 2012 | 22 | 0.100 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2015 | 443 | 0.100 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 35 | 0.100 |
Why?
| | Muscle Development | 1 | 2013 | 108 | 0.100 |
Why?
| | Crystallization | 1 | 2012 | 137 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 952 | 0.100 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 58 | 0.090 |
Why?
| | Polymerization | 1 | 2012 | 124 | 0.090 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 216 | 0.090 |
Why?
| | Base Sequence | 3 | 2017 | 2138 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2013 | 234 | 0.090 |
Why?
| | Sarcopenia | 1 | 2013 | 74 | 0.090 |
Why?
| | Fibrosis | 2 | 2024 | 526 | 0.090 |
Why?
| | Adenocarcinoma | 1 | 2018 | 889 | 0.090 |
Why?
| | Trichuris | 1 | 2011 | 3 | 0.090 |
Why?
| | Trichuriasis | 1 | 2011 | 4 | 0.090 |
Why?
| | Genes, ras | 2 | 2009 | 95 | 0.090 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2011 | 11 | 0.090 |
Why?
| | Antigens, Dermatophagoides | 1 | 2011 | 10 | 0.090 |
Why?
| | Integrases | 2 | 2010 | 117 | 0.090 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 56 | 0.090 |
Why?
| | Eosinophil Granule Proteins | 3 | 2000 | 21 | 0.090 |
Why?
| | Middle Aged | 8 | 2024 | 31087 | 0.090 |
Why?
| | Sepsis | 1 | 2017 | 576 | 0.090 |
Why?
| | Immune Tolerance | 1 | 2013 | 356 | 0.090 |
Why?
| | Bronchial Provocation Tests | 2 | 2011 | 51 | 0.090 |
Why?
| | Phosphines | 1 | 2010 | 17 | 0.090 |
Why?
| | Th1 Cells | 1 | 2011 | 137 | 0.080 |
Why?
| | Goblet Cells | 2 | 2020 | 22 | 0.080 |
Why?
| | Apoptosis | 3 | 2014 | 2488 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3081 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 1050 | 0.080 |
Why?
| | DNA Primers | 2 | 2009 | 507 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 944 | 0.080 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 436 | 0.080 |
Why?
| | Latex | 1 | 2009 | 9 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 789 | 0.080 |
Why?
| | Pentanes | 1 | 2009 | 10 | 0.080 |
Why?
| | Curcumin | 1 | 2009 | 29 | 0.080 |
Why?
| | Hemiterpenes | 1 | 2009 | 11 | 0.080 |
Why?
| | Elastomers | 1 | 2009 | 25 | 0.080 |
Why?
| | Emulsions | 1 | 2009 | 51 | 0.080 |
Why?
| | Dietary Supplements | 1 | 2013 | 532 | 0.080 |
Why?
| | Immunoenzyme Techniques | 2 | 2010 | 211 | 0.080 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 581 | 0.070 |
Why?
| | Respiratory System Agents | 1 | 2008 | 22 | 0.070 |
Why?
| | Cell Extracts | 1 | 2008 | 17 | 0.070 |
Why?
| | Electric Stimulation | 2 | 2000 | 269 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2017 | 2697 | 0.070 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 541 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 2062 | 0.070 |
Why?
| | Pneumococcal Infections | 1 | 2009 | 112 | 0.070 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 171 | 0.070 |
Why?
| | Lipopolysaccharides | 2 | 2024 | 872 | 0.070 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2008 | 42 | 0.070 |
Why?
| | Gait | 1 | 2010 | 263 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2008 | 187 | 0.070 |
Why?
| | 3T3 Cells | 1 | 2007 | 159 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 222 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2010 | 724 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 157 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 398 | 0.070 |
Why?
| | Receptor, Adenosine A3 | 1 | 2006 | 1 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2007 | 227 | 0.060 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 339 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 371 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 315 | 0.060 |
Why?
| | Time Factors | 3 | 2011 | 6530 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 45 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2005 | 33 | 0.060 |
Why?
| | Walking | 1 | 2010 | 491 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 318 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1891 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1708 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 20409 | 0.060 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 611 | 0.060 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 2004 | 4 | 0.060 |
Why?
| | Eye Proteins | 1 | 2024 | 88 | 0.060 |
Why?
| | Pseudomonas aeruginosa | 2 | 2018 | 348 | 0.060 |
Why?
| | Aerosols | 3 | 2010 | 171 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 611 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 832 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 569 | 0.050 |
Why?
| | Pneumonia | 3 | 2017 | 618 | 0.050 |
Why?
| | Organoids | 1 | 2024 | 104 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 259 | 0.050 |
Why?
| | Trachea | 2 | 2020 | 230 | 0.050 |
Why?
| | Transcriptome | 2 | 2019 | 875 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2055 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1636 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 328 | 0.050 |
Why?
| | Age Factors | 1 | 2010 | 3150 | 0.050 |
Why?
| | Adult | 3 | 2021 | 35505 | 0.050 |
Why?
| | Ions | 1 | 2023 | 66 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1770 | 0.050 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 298 | 0.050 |
Why?
| | Diffusion | 1 | 2023 | 117 | 0.050 |
Why?
| | Phenotype | 4 | 2014 | 3058 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2827 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 274 | 0.050 |
Why?
| | Balantidiasis | 1 | 2001 | 1 | 0.050 |
Why?
| | Antibodies | 2 | 2000 | 398 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2021 | 60 | 0.040 |
Why?
| | ErbB Receptors | 2 | 2018 | 605 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 188 | 0.040 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2000 | 9 | 0.040 |
Why?
| | Quinuclidines | 1 | 2000 | 9 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 825 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 79 | 0.040 |
Why?
| | Neutrophil Infiltration | 2 | 2012 | 105 | 0.040 |
Why?
| | Stem Cells | 1 | 2024 | 574 | 0.040 |
Why?
| | Respiration | 1 | 2021 | 193 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 91 | 0.040 |
Why?
| | Cyclophosphamide | 1 | 2000 | 234 | 0.040 |
Why?
| | Trichinellosis | 1 | 2019 | 2 | 0.040 |
Why?
| | Trichinella spiralis | 1 | 2019 | 2 | 0.040 |
Why?
| | Cross Protection | 1 | 2019 | 5 | 0.040 |
Why?
| | Protein Binding | 2 | 2017 | 2121 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 14 | 0.040 |
Why?
| | Haemophilus Infections | 2 | 2010 | 40 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 754 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2014 | 2367 | 0.040 |
Why?
| | Temperature | 1 | 2023 | 635 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 156 | 0.040 |
Why?
| | Surface Properties | 2 | 2012 | 400 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2019 | 3 | 0.040 |
Why?
| | Strongylida Infections | 1 | 2019 | 6 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 65 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 35 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 175 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 405 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 253 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 34 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 200 | 0.040 |
Why?
| | Muscle Strength | 2 | 2013 | 304 | 0.040 |
Why?
| | Immunization | 1 | 2001 | 410 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 60 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 2044 | 0.040 |
Why?
| | Biomarkers, Tumor | 2 | 2018 | 1159 | 0.040 |
Why?
| | Sri Lanka | 1 | 2018 | 7 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 212 | 0.040 |
Why?
| | Intestines | 1 | 2021 | 350 | 0.040 |
Why?
| | Sputum | 1 | 2020 | 302 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1286 | 0.040 |
Why?
| | Larva | 1 | 2019 | 215 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 524 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 146 | 0.040 |
Why?
| | Immunologic Techniques | 1 | 1997 | 39 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 614 | 0.040 |
Why?
| | Body Composition | 2 | 2013 | 649 | 0.040 |
Why?
| | Chemokines | 2 | 2009 | 227 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 23 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 10 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 170 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 763 | 0.030 |
Why?
| | Biopsy | 1 | 2001 | 1087 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2017 | 44 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 94 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 132 | 0.030 |
Why?
| | Acetylcholine | 1 | 1997 | 184 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 151 | 0.030 |
Why?
| | Thermodynamics | 2 | 2009 | 407 | 0.030 |
Why?
| | Epithelial Sodium Channels | 1 | 2016 | 19 | 0.030 |
Why?
| | NF-kappa B | 2 | 2012 | 666 | 0.030 |
Why?
| | Rabbits | 1 | 1997 | 769 | 0.030 |
Why?
| | Aged | 5 | 2015 | 22063 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 6 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 16 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 55 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 31 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 298 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 30 | 0.030 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2015 | 13 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2015 | 3383 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 59 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 235 | 0.030 |
Why?
| | Mucin-4 | 1 | 2014 | 4 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2013 | 0.030 |
Why?
| | Child | 3 | 2021 | 20932 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 590 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 59 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 959 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 554 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2015 | 115 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 221 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2017 | 317 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1250 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 10499 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 275 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 673 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2012 | 4087 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2014 | 310 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 376 | 0.030 |
Why?
| | Whole Body Imaging | 1 | 2013 | 20 | 0.030 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1031 | 0.030 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2012 | 6 | 0.030 |
Why?
| | E-Box Elements | 1 | 2012 | 5 | 0.030 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2012 | 30 | 0.020 |
Why?
| | Ligands | 1 | 2014 | 619 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 139 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 137 | 0.020 |
Why?
| | DNA Methylation | 1 | 2017 | 606 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2012 | 141 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 246 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2012 | 216 | 0.020 |
Why?
| | Cell Separation | 1 | 2013 | 315 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 397 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 221 | 0.020 |
Why?
| | Cecum | 1 | 2011 | 32 | 0.020 |
Why?
| | Arthropod Proteins | 1 | 2011 | 4 | 0.020 |
Why?
| | Bronchoconstrictor Agents | 1 | 2011 | 16 | 0.020 |
Why?
| | Particle Size | 1 | 2012 | 354 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 379 | 0.020 |
Why?
| | Airway Resistance | 1 | 2011 | 35 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 68 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 349 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 461 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 836 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 740 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 936 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 257 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1199 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 296 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 916 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2503 | 0.020 |
Why?
| | Habits | 1 | 2010 | 44 | 0.020 |
Why?
| | Resistance Training | 1 | 2013 | 151 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3772 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1827 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1594 | 0.020 |
Why?
| | Speech | 1 | 2010 | 74 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 287 | 0.020 |
Why?
| | Survival | 1 | 2009 | 38 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2009 | 42 | 0.020 |
Why?
| | Body Height | 1 | 2010 | 194 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2011 | 330 | 0.020 |
Why?
| | Physical Exertion | 1 | 2010 | 208 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1158 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 206 | 0.020 |
Why?
| | Molecular Weight | 1 | 2009 | 329 | 0.020 |
Why?
| | Physical Fitness | 1 | 2010 | 202 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2009 | 119 | 0.020 |
Why?
| | Leg | 1 | 2010 | 222 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2015 | 1261 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2009 | 106 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1873 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2008 | 82 | 0.020 |
Why?
| | Ozone | 1 | 2009 | 103 | 0.020 |
Why?
| | Uridine Triphosphate | 1 | 2008 | 12 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2008 | 134 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 173 | 0.020 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 19 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1053 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 118 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2008 | 87 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 450 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 773 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2008 | 265 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 663 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 311 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 827 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 189 | 0.020 |
Why?
| | Exons | 1 | 2008 | 340 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 851 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2008 | 199 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 56 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1084 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 373 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1870 | 0.020 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2005 | 8 | 0.020 |
Why?
| | Body Weight | 1 | 2010 | 941 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 26 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 353 | 0.020 |
Why?
| | Parasympathetic Nervous System | 1 | 2005 | 27 | 0.020 |
Why?
| | Motor Activity | 1 | 2010 | 686 | 0.020 |
Why?
| | Models, Genetic | 1 | 2008 | 592 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1722 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 843 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 650 | 0.010 |
Why?
| | History, 20th Century | 1 | 2006 | 295 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1326 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 739 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5470 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 5769 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1203 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1327 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2628 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 12438 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2008 | 1118 | 0.010 |
Why?
| | Infant | 1 | 2015 | 9005 | 0.010 |
Why?
| | Diamines | 1 | 1999 | 3 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 1999 | 7 | 0.010 |
Why?
| | Atropine | 1 | 1999 | 24 | 0.010 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 16 | 0.010 |
Why?
| | Muscarinic Agonists | 1 | 1999 | 16 | 0.010 |
Why?
| | Vagotomy | 1 | 1999 | 32 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1999 | 27 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7052 | 0.010 |
Why?
| | Integrins | 1 | 1999 | 93 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 6412 | 0.010 |
Why?
|
|
Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|